Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.10.35 CHF
Change Today -0.25 / -2.36%
Volume 23.5K
As of 11:43 AM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

shl telemedicine ltd-reg (SHLTN) Snapshot

Open
SFr.10.60
Previous Close
SFr.10.60
Day High
SFr.10.75
Day Low
SFr.10.20
52 Week High
05/12/15 - SFr.11.25
52 Week Low
08/4/14 - SFr.7.05
Market Cap
112.6M
Average Volume 10 Days
58.1K
EPS TTM
SFr.0.21
Shares Outstanding
10.9M
EX-Date
09/20/11
P/E TM
52.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for SHL TELEMEDICINE LTD-REG (SHLTN)

Related News

No related news articles were found.

shl telemedicine ltd-reg (SHLTN) Related Businessweek News

No Related Businessweek News Found

shl telemedicine ltd-reg (SHLTN) Details

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine systems in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12-lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter that transmits a patient's complete 12-lead ECG and rhythm read-out strip in real-time to support professional evaluation of medical conditions; Cardio'B, a portable device, which transmits a 12-lead ECG; and CardioBeeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote, electronic, handheld device to test how well the lungs are working; and TelePulse Oximeter, an electronic, handheld diagnostic device to measure the saturation level of oxygen in blood and pulse rate. In addition, it offers medical call center services with a focus on cardiovascular and related diseases to end users, as well as to the healthcare community. The company offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.

448 Employees
Last Reported Date: 03/25/15
Founded in 1987

shl telemedicine ltd-reg (SHLTN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shl telemedicine ltd-reg (SHLTN) Key Developments

SHL Telemedicine Ltd., Q1 2015 Earnings Call, May 28, 2015

SHL Telemedicine Ltd., Q1 2015 Earnings Call, May 28, 2015

SHL Telemedicine Signs Distribution Agreement for the smartheart(TM) Device with FUJIFILM SonoSite

SHL Telemedicine Ltd. announced it has signed an international distribution agreement for its innovative smartheart(TM) device with FUJIFILM SonoSite, Inc. smartheart(TM) is the first and only personal mobile 12-lead ECG device on the market that enables the detection of heart attacks. FUJIFILM SonoSite will distribute the smartheart(TM) device to its professional healthcare customers in the US, Japan and Germany, using its point-of-care ultrasound solutions. With smartheart and a smartphone or tablet they can perform a full hospital grade ECG and send it to a clinic, a hospital or SHL's telemedicine center for diagnosis.

SHL Telemedicine Ltd. Announces Board Changes

SHL Telemedicine Ltd. announced that the board of directors has unanimously resolved to appoint Mr. Eli Alroy to serve as a member of the board. In addition, Mr. Eli Ayalon has announced his resignation from the board of directors effective immediately. Mr. Eli Alroy is the managing director of A.Y.R.A.D. Investment Ltd. From 1994 to 2012, Mr. Alroy was the chairman of the supervisory board of Globe Trade Centre S.A.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHLTN:SW SFr.10.35 CHF -0.25

SHLTN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTelemetry Inc $9.71 USD -0.05
Health Revenue Assurance Holdings Inc $0.0012 USD 0.00
LifeWatch AG SFr.16.60 CHF +0.35
View Industry Companies
 

Industry Analysis

SHLTN

Industry Average

Valuation SHLTN Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHL TELEMEDICINE LTD-REG, please visit www.shl-telemedicine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.